4.5 Article

Growth and nutrition in children with ataxia telangiectasia

Journal

ARCHIVES OF DISEASE IN CHILDHOOD
Volume 101, Issue 12, Pages 1137-1141

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/archdischild-2015-310373

Keywords

-

Categories

Funding

  1. NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton
  2. Harefield NHS Foundation Trust
  3. Imperial College London
  4. NIHR ACL
  5. National Institute for Health Research [CL-2014-12-002] Funding Source: researchfish

Ask authors/readers for more resources

Background Ataxia telangiectasia ( A-T) is a rare multisystem disease with high early mortality from lung disease and cancer. Nutritional failure adversely impacts outcomes in many respiratory diseases. Several factors influence nutrition in children with A-T. We hypothesised that children with A-T have progressive growth failure and that early gastrostomy tube feeding ( percutaneous endoscopic gastrostomy, PEG) is a favourable management option with good nutritional outcomes. Methods Data were collected prospectively on weight, height and body mass index ( BMI) at the national paediatric A-T clinic. Adequacy and safety of oral intake was assessed. Nutritional advice was given at each multidisciplinary review. Results 101 children ( 51 girls) had 222 measurements ( 32 once, 32 twice, 24 thrice) between 2009 and 2016. Median ( IQR) age was 9.3 ( 6.4 to 13.1) years. Mean ( SD) weight, height and BMI Z-scores were respectively -1 ( 1.6), -1.2 ( 1.2) and -0.4 ( 1.4). 35/101 children had weight Z-scores below -2 on at least one occasion. Weight, height and BMI Z-scores declined over time. Decline was most obvious after 8 years of age. 14/101 ( 14%) children had a PEG, with longitudinal data available for 12. In a nested case control study, there was a trend for improvement in weight in those with a PEG ( p=0.10). Conclusions Patients with A-T decline in growth over time. There is an urgent need for new strategies, including an understanding of why growth falters. We suggest early proactive consideration of PEG from age 8 years onwards to prevent progressive growth failure.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available